eTMF market to grow sizably over next three years, ISR reports

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/ArtemSam)
(Image: iStock/ArtemSam)
The adoption of eTMF solutions is accelerating – with more than 50% of investigative sites expected to have access to a sponsor/CRO eTMF application within three years.

This figure is according to a recent report​ published by Industry Standard Research (ISR), which assessed eTMF (electronic trial master file) application access to be around 20% today.

Andrew Schafer, President, Industry Standard Research (ISR) said the driving demand is “simply an evolution​” of pharmaceutical and service providers to web-based applications.

Schafer compared the shift in the market to the adoption curve of other eClinical technologies, such as EDC, eCOA, ePRO, and IRT/IVR.

Based on those services and what we have witnessed, early and high market penetration is key to long-term success in these markets​,” he told us. “There are certainly clear leadership positions being established, but there is also a segment of providers that can easily climb into the top share positions​.”

According to the report, survey respondents – including both pharma and CROs – recently interacted with two eTMF systems.

It will be interesting, if the data hold and sites gain more access to CRO/sponsor eTMF systems, then sites will quickly be ‘burdened’ with having to navigate many more eTMF systems, just as they do with EDC systems today​,” said Schafer.

Related topics: Markets & Regulations, Data management

Related news

Show more

Related products

show more

Paper vs ePRO Data Collection Methods

Paper vs ePRO Data Collection Methods

Signant Health | 19-Oct-2021 | Technical / White Paper

Are you curious why more Sponsors choose digital data collection methods over the traditional pen and paper? Read this recent white paper to discover the...

GLP Tissue Cross Reactivity Testing

GLP Tissue Cross Reactivity Testing

Precision for Medicine | 11-Oct-2021 | Product Brochure

Precision for Medicine's unique combination of research services and tissue procurement capabilities form the pillars of our GLP Tissue Cross Reactivity...

Related suppliers

Follow us


View more